lysophosphatidic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aidinis, V; Antoniou, K; Karampitsakos, T; Matralis, AN; Ntatsoulis, K; Stylianaki, EA; Tsitoura, E; Tzouvelekis, A | 1 |
1 review(s) available for lysophosphatidic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Topics: Anti-Inflammatory Agents; COVID-19; Dexamethasone; Humans; Lung; Lysophospholipids; Phosphoric Diester Hydrolases; Pulmonary Fibrosis; Respiratory Distress Syndrome; SARS-CoV-2; Signal Transduction | 2021 |